91 – 100 of 142
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression
Stenström, Jenny ; Hedenfalk, Ingrid LU
and Hagerling, Catharina
LU
(2021)
In Breast Cancer Research
23(1).
- Contribution to journal › Article
-
Mark
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
- Contribution to journal › Article
-
Mark
Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers
Haugen, Mads H. ; Lingjærde, Ole Christian ; Hedenfalk, Ingrid LU
; Garred, Øystein
; Borgen, Elin
; Loman, Niklas
LU
; Hatschek, Thomas
; Børresen-Dale, Anne Lise
; Naume, Bjørn
and Mills, Gordon B.
, et al.
(2021)
In JCO Precision Oncology
5.
p.286-306
- Contribution to journal › Article
-
Mark
Homologous recombination repair mechanisms in serous endometrial cancer
Jönsson, Jenny Maria LU ; Bååth, Maria LU ; Björnheden, Ida ; Sahin, Irem Durmaz LU ; Måsbäck, Anna LU and Hedenfalk, Ingrid LU
(2021)
In Cancers
13(2).
- Contribution to journal › Article
-
Mark
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila LU ; Akrap, Nina LU ; Staaf, Johan LU
; Alves, Carla L
; Ehinger, Anna
LU
; Ebbesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Beumers, Lukas
LU
; Veerla, Srinivas
LU
and Harbst, Katja
LU
, et al.
(2021)
In Breast cancer research : BCR
23(1).
p.26-26
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
Maguire, Sarah ; Olsson, Håkan LU
; Hedenfalk, Ingrid
LU
and Orr, Nick
(2021)
In Journal of the National Cancer Institute
113(4).
p.453-461
- Contribution to journal › Article
-
Mark
Breast cancer risk genes - Association analysis in more than 113,000 women
Dorling, Leila ; Valcich, Jeanette LU ; Li, Minerva LU ; Törngren, Therese LU ; Borg, Åke LU ; Kvist, Anders LU
and Easton, Douglas F.
(2021)
In New England Journal of Medicine
384(5).
p.428-439
- Contribution to journal › Article
- 2020
-
Mark
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
Persson, Helena LU
; Søkilde, Rolf
LU
; Häkkinen, Jari
LU
; Vallon-Christersson, Johan
LU
; Mitelman, Felix
LU
; Borg, Åke
LU
; Höglund, Mattias
LU
and Rovira, Carlos
LU
(2020)
In International Journal of Cancer
146(12).
p.3343-3353
- Contribution to journal › Article
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Westbom-Fremer, Sofia LU
; Arildsen, Nicolai Skovbjerg
LU
; Hartman, Linda
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
and Hedenfalk, Ingrid
LU
(2020)
In Virchows Archiv: an international journal of pathology
477(1).
p.83-91
- Contribution to journal › Article
-
Mark
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
Larsson, Christer LU ; Ehinger, Anna LU
; Winslow, Sofia
LU
; Leandersson, Karin
LU
; Klintman, Marie
LU
; Dahl, Ludvig
; Vallon-christersson, Johan
LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
and Manjer, Jonas
LU
, et al.
(2020)
In npj Breast Cancer
6(1).
- Contribution to journal › Article